Similar articles

• Lack of low Km diazepam N-demethylase in livers of poor metabolizers for S-mephenytoin 4'-hydroxylation.

  Yasumori T, Li QH, Yamazoe Y, Ueda M, Tsuzuki T, Kato R. Yasumori T, et al. Pharmacogenetics. 1994 Dec;4(6):323-31. doi: 10.1097/00008571-199412000-00005. Pharmacogenetics. 1994. PMID: 7704038
• Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs.

  Koyama E, Chiba K, Tani M, Ishizaki T. Koyama E, et al. J Pharmacol Exp Ther. 1997 Jun;281(3):1199-210. J Pharmacol Exp Ther. 1997. PMID: 9190854
• The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine.

  Skjelbo E, Brøsen K, Hallas J, Gram LF. Skjelbo E, et al. Clin Pharmacol Ther. 1991 Jan;49(1):18-23. doi: 10.1038/clpt.1991.4. Clin Pharmacol Ther. 1991. PMID: 1988236
• Polymorphism in stereoselective hydroxylations of mephenytoin and hexobarbital by Japanese liver samples in relation to cytochrome P-450 human-2 (IIC9).

  Kato R, Yamazoe Y, Yasumori T. Kato R, et al. Xenobiotica. 1992 Sep-Oct;22(9-10):1083-92. doi: 10.3109/00498259209051862. Xenobiotica. 1992. PMID: 1441599 Review.
• Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions.

  Meyer UA. Meyer UA. Yale J Biol Med. 1996 May-Jun;69(3):203-9. Yale J Biol Med. 1996. PMID: 9165689 Free PMC article. Review.